Inflammatory Bowel Disease
Conditions
Brief summary
Difference in relapse rate
Detailed description
Factors associated with successful interval extension, Proportion of patients having needed corticosteroïd treatment during follow-up, Differences in emergency visits, hospitalizations and surgery, Difference in quality of life, Cost-effectiveness of interval extension, Differences in adverse events, Vedolizumab pharmacodynamics and pharmacokinetics
Interventions
Sponsors
Stichting Amsterdam UMC
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in relapse rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors associated with successful interval extension, Proportion of patients having needed corticosteroïd treatment during follow-up, Differences in emergency visits, hospitalizations and surgery, Difference in quality of life, Cost-effectiveness of interval extension, Differences in adverse events, Vedolizumab pharmacodynamics and pharmacokinetics | — |
Countries
Netherlands
Outcome results
None listed